D
RenovoRx, Inc. RNXT
$0.972 -$0.018-1.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 10.81% -73.89% -2.66% 66.96% -49.68%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -63.22% 101.72% 79.94% -360.11% 878.05%
Change in Net Operating Assets 66.98% 1,044.44% -59.17% -199.47% -238.26%
Cash from Operations -18.36% 19.57% 17.11% 18.55% -22.13%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- -100.00%
Cash from Investing -- -- -- -- -100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- 92.92% 90,233.33% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- 92.92% 90,233.33% -100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -17.34% 20.12% 229.58% 581.44% -258.17%